Shao-liang Y. Zhu
China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Letter: hepatocellular carcinoma surveillance determines survival in patients at risk.
Journal: Alimentary pharmacology & therapeutics
Published: September 19, 2019
Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta-analysis.
Journal: Molecular genetics & genomic medicine
Published: October 26, 2018
A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma.
Journal: Scientific reports
Published: January 31, 2018
A combination of subcuticular suture and enhanced recovery after surgery reduces wound complications in patients undergoing hepatectomy for hepatocellular carcinoma.
Journal: Scientific reports
Published: January 30, 2018
Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Journal: World journal of gastroenterology
Published: July 26, 2017
Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus.
Journal: OncoTargets and therapy
Published: December 13, 2016
Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection.
Journal: OncoTargets and therapy
Published: November 24, 2016
GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer.
Journal: Oncotarget
Published: October 07, 2016
Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Journal: OncoTargets and therapy
Published: August 09, 2016
Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy.
Journal: OncoTargets and therapy
Published: July 28, 2016
The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.
Journal: BMC cancer
Published: July 20, 2016
Genetic polymorphisms -137 (rs187238) and -607 (rs1946518) in the interleukin-18 promoter may not be associated with development of hepatocellular carcinoma.
Journal: Scientific reports
Published: July 11, 2016
Last Updated: 09/26/2026